Strikingly, when TLR4 was inhibited, the production of both TNF-α and IL-1β was significantly decreased, thus ultimately suggesting a potential TLR4–mediated inflammatory response in the MPS IIIA disease. The gene discussed is TLR4; the disease is mucopolysaccharidosis type 3A.